Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma

Author:                

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.41, Iss.2, 2012-01, pp. : 712-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content